Interventional Oncology Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Ablation Devices is the fastest growing segment, North America is the largest regional market

The Global Interventional Oncology Devices Market, valued at USD 2.74 Billion in 2024, is projected to experience a CAGR of 7.90% to reach USD 4.32 Billion by 2030. Interventional oncology devices represent specialized medical instrumentation employed in image-guided, minimally invasive procedures for the diagnosis, treatment, and palliation of various cancers. The market's expansion is fundamentally driven by the increasing global prevalence of cancer and a growing preference for less invasive therapeutic interventions, which offer advantages such as reduced recovery times and fewer complications.

Key Market Drivers

The increasing global cancer incidence is a significant catalyst for the interventional oncology devices market, generating an expanding patient demographic in need of advanced diagnostic and treatment modalities. The rising number of new cancer diagnoses globally creates a fundamental demand for minimally invasive, image-guided interventions that offer targeted therapy with reduced systemic impact.

For example, according to the "Global Cancer Statistics, 2024" report published by the American Cancer Society and the International Agency for Research on Cancer on April 4, 2024, lung cancer was the most frequently diagnosed cancer in 2022, accounting for 2.5 million new cases worldwide, underscoring the substantial and ongoing demand for specialized oncology solutions. This growing burden necessitates a wider array of effective and less invasive tools, directly stimulating the development and adoption of interventional oncology devices.

Key Market Challenges

A notable challenge impeding market expansion is the limited availability of adequately trained interventional oncologists. These specialized medical procedures necessitate a high degree of expertise in image-guided, minimally invasive techniques, making the presence of skilled professionals critical for the adoption and utilization of associated devices. A deficiency in this expert workforce directly restricts the number of procedures that can be performed, thereby hampering the overall demand for interventional oncology instruments.

This scarcity limits patient access to advanced therapeutic interventions and constrains the market's growth potential.

Key Market Trends

Artificial Intelligence and Machine Learning Integration for Precision marks a significant trend in the Global Interventional Oncology Devices Market by refining diagnostic accuracy and therapeutic targeting. The application of sophisticated algorithms allows for the analysis of complex patient data, including genomics and imaging, to guide more precise interventions. According to a EuroAIM/EuSoMII 2024 survey, nearly 48% of European Society of Radiology members are currently using AI systems in their clinical practice, indicating a notable adoption rate within a directly relevant medical specialty. This integration facilitates optimized treatment pathways and improved patient stratification.

Key Market Players Profiled:

Medtronic PLC
Terumo Corporation
Boston Scientific Corporation
Merit Medical Systems, Inc.
HealthTronics, Inc.
Johnson & Johnson
Teleflex Inc.
Angiodynamics Inc.
MedWaves, Inc.
Becton, Dickinson, and Company

Report Scope:

In this report, the Global Interventional Oncology Devices Market has been segmented into the following categories:

By Product:

Embolization Devices
Ablation Devices
Support Devices

By Procedure:

Thermal Tumor Ablation
Non-thermal Tumor Ablation
Transcatheter Arterial Chemoembolization (TACE)
Transcatheter Arterial Radioembolization (TARE)
Transcatheter Arterial Embolization (TAE)

By Cancer Type:

Liver
Kidney
Lung
Bone
Others

By Region:

North America
Europe
Asia-Pacific
South America
Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Interventional Oncology Devices Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Interventional Oncology Devices Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Embolization Devices, Ablation Devices, Support Devices)
5.2.2. By Procedure (Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Transcatheter Arterial Embolization (TAE))
5.2.3. By Cancer Type (Liver, Kidney, Lung, Bone, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map

6. North America Interventional Oncology Devices Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Procedure
6.2.3. By Cancer Type
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Interventional Oncology Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Procedure
6.3.1.2.3. By Cancer Type
6.3.2. Canada Interventional Oncology Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Procedure
6.3.2.2.3. By Cancer Type
6.3.3. Mexico Interventional Oncology Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Procedure
6.3.3.2.3. By Cancer Type

7. Europe Interventional Oncology Devices Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Procedure
7.2.3. By Cancer Type
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Interventional Oncology Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Procedure
7.3.1.2.3. By Cancer Type
7.3.2. France Interventional Oncology Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Procedure
7.3.2.2.3. By Cancer Type
7.3.3. United Kingdom Interventional Oncology Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Procedure
7.3.3.2.3. By Cancer Type
7.3.4. Italy Interventional Oncology Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Procedure
7.3.4.2.3. By Cancer Type
7.3.5. Spain Interventional Oncology Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Procedure
7.3.5.2.3. By Cancer Type

8. Asia-Pacific Interventional Oncology Devices Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Procedure
8.2.3. By Cancer Type
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Interventional Oncology Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Procedure
8.3.1.2.3. By Cancer Type
8.3.2. India Interventional Oncology Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Procedure
8.3.2.2.3. By Cancer Type
8.3.3. Japan Interventional Oncology Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Procedure
8.3.3.2.3. By Cancer Type
8.3.4. South Korea Interventional Oncology Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Procedure
8.3.4.2.3. By Cancer Type
8.3.5. Australia Interventional Oncology Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Procedure
8.3.5.2.3. By Cancer Type

9. Middle East & Africa Interventional Oncology Devices Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Procedure
9.2.3. By Cancer Type
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Interventional Oncology Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Procedure
9.3.1.2.3. By Cancer Type
9.3.2. UAE Interventional Oncology Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Procedure
9.3.2.2.3. By Cancer Type
9.3.3. South Africa Interventional Oncology Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Procedure
9.3.3.2.3. By Cancer Type

10. South America Interventional Oncology Devices Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Procedure
10.2.3. By Cancer Type
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Interventional Oncology Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Procedure
10.3.1.2.3. By Cancer Type
10.3.2. Colombia Interventional Oncology Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Procedure
10.3.2.2.3. By Cancer Type
10.3.3. Argentina Interventional Oncology Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Procedure
10.3.3.2.3. By Cancer Type

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Interventional Oncology Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Medtronic PLC
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Terumo Corporation
15.3. Boston Scientific Corporation
15.4. Merit Medical Systems, Inc.
15.5. HealthTronics, Inc.
15.6. Johnson & Johnson
15.7. Teleflex Inc.
15.8. Angiodynamics Inc.
15.9. MedWaves, Inc.
15.10. Becton, Dickinson, and Company

16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Interventional Oncology Devices market report include:

Medtronic PLC
Terumo Corporation
Boston Scientific Corporation
Merit Medical Systems, Inc.
HealthTronics, Inc.
Johnson & Johnson
Teleflex Inc.
Angiodynamics Inc.
MedWaves, Inc.
Becton, Dickinson, and Company

Table Information

Report Attribute	Details
No. of Pages	185
Published	November 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.74 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.32 Billion
Compound Annual Growth Rate	7.9%
Regions Covered	Global
No. of Companies Mentioned	11

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3965EUR$4,500USD£3,483GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4847EUR$5,500USD£4,257GBP

Key Market Drivers

Key Market Challenges

Key Market Trends

Key Market Players Profiled:

Report Scope:

By Product:

By Procedure:

By Cancer Type:

By Region:

Competitive Landscape

Available Customizations:

Company Information

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Interventional Oncology Devices Market Report 2025

Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung), End User (Hospital, Specialty Clinic) - Global Forecast to 2029

Interventional Oncology Market Report 2025

Interventional Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Interventional Oncology Devices - Global Strategic Business Report